| Trial ID: | L4629 |
| Source ID: | NCT00873223
|
| Associated Drug: |
Liraglutide
|
| Title: |
Examination of the Effects of Liraglutide on the Mode of Action of Insulin Detemir
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: liraglutide|DRUG: insulin detemir
|
| Outcome Measures: |
Primary: Insulin detemir pharmacokinetics with and without liraglutide administration, at approx. 12 weeks (including screening, washout and evaluation period) | Secondary: Pharmacokinetics of liraglutide with and without insulin detemir, at approx. 12 weeks (including screening, washout and evaluation period)
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
33
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2009-03
|
| Completion Date: |
2009-09
|
| Results First Posted: |
|
| Last Update Posted: |
2017-01-26
|
| Locations: |
Novo Nordisk Investigational Site, Chula Vista, California, 91911, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00873223
|
